B
Bhumika
About Bhumika
Data last updated:
Bhumika has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Delbruk Lifescience Private Limited and Delbruk Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Delbruk Lifescience Private Limited at ₹9.41 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Delbruk Lifescience Private Limited U33301WB2020PTC237106 | Director | 21 Apr 2021 | 2020 | ₹9.41 Cr (FY 2025) | Active |
 Delbruk Pharmaceuticals Private Limited U33119DL2023PTC410253 | Director | 20 Jan 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhumika
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhumika
Bhumika has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Delbruk Lifescience Private Limited and Delbruk Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Delbruk Lifescience Private Limited at ₹9.41 Cr (FY 2025).
Bhumika is associated with 2 companies as Director, including Delbruk Lifescience Private Limited (₹9.41 Cr), Delbruk Pharmaceuticals Private Limited.
Bhumika has expertise in General Business.
Bhumika has 5 years in corporate governance.
By reported revenue, the largest current company of Bhumika is Delbruk Lifescience Private Limited, with revenue of ₹9.41 Cr (FY 2025).
Bhumika currently holds positions at 2 companies: Delbruk Lifescience Private Limited (₹9.41 Cr), Delbruk Pharmaceuticals Private Limited.